# A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.

> **NCT05230186** · — · UNKNOWN · sponsor: **TScan Therapeutics, Inc.** · enrollment: 200 (estimated)

## Conditions studied

- Solid Tumor, Adult

## Interventions

- **PROCEDURE:** Tumor Biopsy

## Key facts

- **NCT ID:** NCT05230186
- **Lead sponsor:** TScan Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-26
- **Primary completion:** 2024-12-23
- **Final completion:** 2024-12-23
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05230186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05230186, "A Tissue Collection Study in Patients Who Respond to Immune Checkpoint Inhibitors to Identify Targets of Tumor-Reactive T Cells.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05230186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*